Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Levodopa/carbidopa/entacapone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Levodopa 50mg / Carbidopa 12.5mg / Entacapone 200mg tablets
0409010X0AAAAAA
|
Levodopa/carbidopa/entacapone | Levodopa/carbidopa/entacapone | Central Nervous System | 217 |
|
Stanek 50mg/12.5mg/200mg tablets
0409010X0BDAEAA
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 215 |
|
Sastravi 50mg/12.5mg/200mg tablets (Accord Healthcare Ltd)
0409010X0BCAIAA
|
Sastravi | Levodopa/carbidopa/entacapone | Central Nervous System | 199 |
|
Levodopa 75mg / Carbidopa 18.75mg / Entacapone 200mg tablets
0409010X0AAAEAE
|
Levodopa/carbidopa/entacapone | Levodopa/carbidopa/entacapone | Central Nervous System | 161 |
|
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd)
0409010X0BCAFAG
|
Sastravi | Levodopa/carbidopa/entacapone | Central Nervous System | 64 |
|
Sastravi 50mg/12.5mg/200mg tablets (Actavis UK Ltd)
0409010X0BCABAA
|
Sastravi | Levodopa/carbidopa/entacapone | Central Nervous System | 46 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.